| Literature DB >> 19707384 |
Haruna Takano1, Satoshi Murasawa, Takayuki Asahara.
Abstract
Telomerase dysfunction contributes to cellular senescence. Recent advances indicate the importance of senescence in maintaining vascular cell function in vitro. Human telomerase reverse transcriptase (hTERT) overexpression is thought to lead to resistance to apoptosis and oxidative stress. However, the mechanism in endothelial lineage cells is unclear. We tried to generate an immortal endothelial cell line from human umbilical vein endothelial cells using a no-virus system and examine the functional mechanisms of hTERT overexpressed endothelial cell senescence in vitro. High levels of hTERT genes and endothelial cell-specific markers were expressed during long-term culture. Also, angiogenic responses were observed in hTERT over-expressed endothelial cell. These cells showed a delay in senescence and appeared more resistant to stressed conditions. PI3K/Akt-related gene levels were enhanced in hTERT overexpressed endothelial cells. An up-regulated PI3K/Akt pathway caused by hTERT overexpression might contribute to anti-apoptosis and survival effects in endothelial lineage cells.Entities:
Keywords: PI3K/Akt pathway; anti-apoptosis; endothelial; oxidative stress; senescence; telomerase
Year: 2008 PMID: 19707384 PMCID: PMC2721385 DOI: 10.2147/btt.s2479
Source DB: PubMed Journal: Biologics ISSN: 1177-5475
List of primer sequences for PCR
| Molecule | Sense (5’–3’) | Antiense (5’–3’) |
|---|---|---|
| hTERT | CACCTCACCTCACCCACGCGAAA | CCAAAGAGTTTGCGACGCATGTT |
| hCD31 | AGGACATCCATGTTCCGAGA | TGAACCGTGTCTTCAGGTTG |
| hKDR | CCCTGCCGTGTTGAAGAGTT | GGACAGGGGGAAGAACAAAA |
| heNOS | TTACCATGGCAACCAACGTC | AAAAGCTCTGGGTGCGTATG |
| hGAPDH | GCCCCAGCAAGAGCACAAGA | TAGGCCCCTCCCCTCTTCAA |
Figure 1hTERT transduced HUVECs expressed telomerase genes during long-term culture. RNA samples from transduced HUVECs were analyzed by RT-PCR for gene expression. (A) Expression of hTERT gene in 293 cells served as the positive standard. (B) Expression of endothelial markers.
Figure 2Transduced HUVEC lines maintained endothelial characteristics. (A) Growth of transduced HUVECs, Td/mock (day 159) and Td/TERT (day 124), was inhibited in low serum (*p < 0.001, ** p < 0.05). (B) Growth curves of transduced HUVEC. About in a month, most transduced HUVECs showed almost a typical senescent endothelial morphology and stopped continuous growth. However, hTERT overexpression allowed the maintanance of a relatively normal endothelial morphology during the aging process. (C) Phase microscopy demonstrated endothelial morphology of Td/TERTs (day 96) and Td/mocks (day 25). Original magnification x100.
Figure 3Senescence in transduced HUVECs was evaluated by SA-Gal staining. (A) Quantification of SA-Gal–positive cells in transduced HUVECs obtained by counting 5 random fields per dish (p < 0.001 vs Td/mocks). (B) Representative photomicrographs show SA-Gal–positive cells (blue) in Td/TERTs (day 105) and Td/mocks (day 32). Original magnification x100. hTERT overexpression exceeded mitogenic potential. (C) Proliferative activity assay response to VEGF165. (D) Proliferative activity assay response to bFGF. The increase in mitogenic response to angiogenic cytokines of Td/TERTs (day 73) was statistically significant compared with Td/mocks (day 59) (VEGF: p < 0.001; bFGF: p < 0.001 vs Td/mocks).
Figure 4hTERT transduction contributes to cell survival. (A) Representative photomicrographs show Annexin-V (green), propidium iodide (red), and nuclei were stained with blue-fluorescent Hoechst 33342. Original magnification x100. (B) Quantification of apoptosis-induced. The number of apoptotic cells was significantly increased in Td/mocks (p < 0.001) vs Td/TERTs. (C) Oxidative stress measurement in live cells. Representative photomicrographs show the cells stained with carboxy-H2DCFDA (green), corresponding to oxidized cells by ROS, and nuclei were stained with blue-fluorescent Hoechst 33342. Original magnification x100. (D) Quantification of oxidatively damaged cells. The oxidatively damaged cells significantly increased in Td/mocks (p < 0.001) vs Td/TERTs.
Gene array analysis of transduced HUVECs
| Gene bank | Symbol | Gene name | Description | |
|---|---|---|---|---|
| NM021158 | C20orf97 | TRB3 | Chromosome 20 open reading frame 97 | |
| NM002074 | GNB1 | GNB1 | Guanine nucleotide binding protein (G protein), beta polypeptide 1 | |
| NM000883 | IMPDH1 | IMPDH1 | IMP (inosine monophosphate) dehydrogenase 1 | |
| NM005541 | INPP5D | SHIP | Inositol polyphosphate-5- phosphatase,145kDa | |
| NM014221 | MTCP1 | MTCP1 | Mature T-cell proliferation 1 | |
| NM006218 | PIK3CA | p110alpha | phosphoinositide-3kinase, catalytic, alpha polypeptide | |
| NM006219 | PIK3CB | p110beta | phosphoinositide-3kinase, catalytic, beta polypeptide | |
| NM003629 | PIK3R3 | p55 gamma | Phosphoinositide-3-kinase,regulatory subunit, polypeptide 3 (p55, gamma) | |
| NM181897 | PPP2R3A | PPP2R3A | Protein phosphatase 2 (formerly 2A), regulatory subunit B, alpha | |
| NM006246 | PPP2R5E | PPP2R5E | Protein phosphatase 2, regulatory subunit B, (B56), epsilon isoform | |
| NM002737 | PRKCA | PKC alpha | Protein kinase C, alpha | |
| NM002093 | GSK3B | GSK3 | Glycogen synthase kinase 3 beta | |
| NM005923 | MAP3K5 | MEKK5/ASK1 | Mitogen-activated protein kinase kinase kinase 5 | |
| NM005938 | MLLT7 | AFX1 | Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophia);translocated to,7 | |
| NM002467 | MYC | c-Myc | V-myc myelocytomatosis viral oncogene homolog (avian) | |
| NM003998 | NFKB1 | KBF1 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105) | |
| NM020529 | NFKBIA | IKBA/MAD-3 | Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | |
| NM001278 | CHUK | IKKA/IKK1 | Conserved helix-loop-helix ubiquitous kinase | |
| NM002576 | PAK1 | Pak1 | P21/Cdc42/Rac1-activated kinase 1 (STE20 homolog, yeast) | |
| NM012296 | GAB2 | GAB2 | GRB2-associated binding protein 2 | |
| NM004536 | BIRC1 | NAIP | Baculoviral IAP repeat-containing protein 1 (Neuronal apoptosis inhibitory protein) | |
| NM003810 | TNFSF10 | TRAIL | Tumor necrosis factor (ligand) superfamily member, 10 | |
| NM003701 | TNFSF11 | TRANCE | Tumor necrosis factor (ligand) superfamily member, 11 | |
| NM003811 | TNFSF9 | 4-1BB-L | Tumor necrosis factor (ligand) superfamily member, 9 | |
| NM001561 | TNFRSF9 | 4-1BB | Tumor necrosis factor receptor superfamily member, 9 | |
| NM002983 | CCL3 | MIP-1a/SCYA3 | Chemokine (C-C motif) ligane 3 (Macrophage inflammatory protein 1-alpha) | |
| NM021027 | UGT1A9 | UGT1A9 | UDP glycosyltransferase 1 family, polypeptide A9 |
cDNA microarrays were performed to analyze the gene expression of transduced HUVECs. PI3K/Akt related gene levels were enhanced in Td/hTERTs compared with Td/mocks.
+: 2- to < 4-fold up-regulation in Td/hTERT,
++: 4- to < 10-fold up-regulation in Td/hTERT,
+++: 10- or > 10-fold up-regulation in Td/hTERT compared with Td/mock.